Physician profile
Pan S Ko
NPI 1083851687
$15,617.11
in general payments reported to CMS, 2019-2025
29 companies · $1,666 in 2025
The $1,666 reported for 2025 was more than what 84% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,180 · 2020: $3,327 · 2021: $1,940 · 2022: $1,467 · 2023: $1,585 · 2024: $1,452 · 2025: $1,666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,703.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $5,809.86 | 2019-2020 | |
| Gilead Sciences, INC. | $2,883.92 | 2019-2025 | Veklury, Biktarvy |
| Viiv Healthcare Company | $1,142.60 | 2019-2025 | Cabenuva, Dovato, Apretude |
| Smith+Nephew, INC. | $722.55 | 2021-2023 | Collagenase Santyl, Acticoat 4" X 4", Iodosorb Ointment 40g USA |
| Abbvie INC. | $630.35 | 2019-2025 | |
| Insmed, INC. | $617.98 | 2019-2025 | Arikayce, Brinsupri |
| Organogenesis INC. | $547.57 | 2020-2025 | Puraply Wound Matrix, Apligraf, Affinity |
| Merck Sharp & Dohme LLC | $406.13 | 2019-2025 | Zerbaxa, Dificid, Pifeltro |
| Celltrion Healthcare Co., LTD | $300.00 | 2021 | |
| Integra Lifesciences Corporation | $274.93 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Sanofi-Aventis U.S. LLC | $259.37 | 2021 | |
| Paratek Pharmaceuticals, INC. | $233.05 | 2021-2025 | Nuzyra |
| Janssen Pharmaceuticals, INC | $153.47 | 2019-2021 | |
| Horizon Therapeutics Plc | $142.98 | 2020-2023 | Krystexxa |
| Tactile Systems Technology INC | $142.06 | 2025 | Nimbl, Flexitouch Plus |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $138.41 | 2020-2023 | Symtuza |
| Janssen Products, LP | $129.94 | 2021 | |
| Melinta Therapeutics, LLC | $129.56 | 2019-2022 | |
| Urgo Medical North America, LLC | $126.20 | 2024 | Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Abbott Laboratories | $125.00 | 2024 | Eterna |
| Radius Health, INC. | $122.04 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.36 | 2019 | |
| Emd Serono, INC. | $119.11 | 2024-2025 | |
| Intuity Medical INC | $113.57 | 2022 | |
| Octapharma USA, INC. | $72.30 | 2020-2022 | |
| Napo Pharmaceuticals INC | $46.00 | 2023 | Mytesi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.06 | 2019-2024 | Xifaxan, Trulance |
| Invivyd INC | $33.45 | 2025 | Pemgarda |
| Cardiovascular Systems INC. | $31.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pan Ko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.